GT200400134A - Sistemas emulsionantes que contienen derivados de azetidina - Google Patents
Sistemas emulsionantes que contienen derivados de azetidinaInfo
- Publication number
- GT200400134A GT200400134A GT200400134A GT200400134A GT200400134A GT 200400134 A GT200400134 A GT 200400134A GT 200400134 A GT200400134 A GT 200400134A GT 200400134 A GT200400134 A GT 200400134A GT 200400134 A GT200400134 A GT 200400134A
- Authority
- GT
- Guatemala
- Prior art keywords
- azetidine
- emulsioning
- systems containing
- containing derivatives
- derivatives
- Prior art date
Links
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical class C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA PRESENTE INVENCION SER REFIERE A NUEVAS FORMULACIONES DE DERIVADOS DE AZETIDINA PARA ADMINISTRACION ORAL, QUE TIENE FORMULAS (IA) Y (IB), QUE SE ENCUENTRAN EN LA MEMORIA DESCRIPTIVA, DICHAS FORMULACIONES SE PUEDEN UTILIZAR PRA EL TRATAMIENTO DE TRASTORNOS COMO LA OBESIDAD, ESQUIZOFRENIA, ENFERMEDAD DE PARKINSON ETC.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03291797A EP1498123A1 (en) | 2003-07-18 | 2003-07-18 | Emulsifying systems containing azetidine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200400134A true GT200400134A (es) | 2005-02-22 |
Family
ID=33462260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200400134A GT200400134A (es) | 2003-07-18 | 2004-07-16 | Sistemas emulsionantes que contienen derivados de azetidina |
Country Status (31)
Country | Link |
---|---|
US (1) | US20050037062A1 (es) |
EP (2) | EP1498123A1 (es) |
JP (1) | JP2009513559A (es) |
KR (1) | KR20060040690A (es) |
CN (1) | CN1822830A (es) |
AR (1) | AR045912A1 (es) |
AU (1) | AU2004262497A1 (es) |
BR (1) | BRPI0412239A (es) |
CA (1) | CA2532668A1 (es) |
CR (1) | CR8178A (es) |
EC (1) | ECSP066291A (es) |
GT (1) | GT200400134A (es) |
HR (1) | HRP20060021A2 (es) |
IL (1) | IL173113A0 (es) |
MA (1) | MA27921A1 (es) |
MX (1) | MXPA06000478A (es) |
MY (1) | MY142076A (es) |
NO (1) | NO20060510L (es) |
NZ (1) | NZ544707A (es) |
OA (1) | OA13190A (es) |
PA (1) | PA8606601A1 (es) |
PE (1) | PE20050699A1 (es) |
RS (1) | RS20050971A (es) |
RU (1) | RU2348615C2 (es) |
SG (1) | SG144140A1 (es) |
TN (1) | TNSN06012A1 (es) |
TW (1) | TW200522946A (es) |
UA (1) | UA82539C2 (es) |
UY (1) | UY28422A1 (es) |
WO (1) | WO2005013972A1 (es) |
ZA (1) | ZA200600489B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1498122A1 (en) * | 2003-07-18 | 2005-01-19 | Aventis Pharma S.A. | Semi-solid systems containing azetidine derivatives |
JP2009513642A (ja) * | 2005-10-25 | 2009-04-02 | アボット・ラボラトリーズ | 低水溶解度の薬剤を含む製剤およびそれの使用方法 |
CN106236181A (zh) * | 2006-09-29 | 2016-12-21 | 普拉罗美德公司 | 碎石术期间预防结石和结石碎片后退的方法 |
KR101493546B1 (ko) * | 2007-08-21 | 2015-02-16 | 바실리어 파마슈티카 아게 | 항균 조성물 |
FR2923719B1 (fr) * | 2007-11-15 | 2009-11-20 | Sanofi Aventis | Compositions pharmaceutiques a base de derives d'azetidine |
IT1394400B1 (it) * | 2009-02-25 | 2012-06-15 | Neuroscienze Pharmaness S C Ar L | Composizioni farmaceutiche |
CA2982162C (en) | 2015-04-10 | 2023-10-10 | Bioresponse, L.L.C. | Self-emulsifying formulations of dim-related indoles |
CN106551902B (zh) * | 2015-09-17 | 2020-07-03 | 阿赖耶识(上海)生物技术有限公司 | 一种高稳定的非囊泡型纳米颗粒及其在治疗微生物感染中的应用 |
JOP20190260A1 (ar) | 2017-05-02 | 2019-10-31 | Merck Sharp & Dohme | صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها |
CA3060581A1 (en) | 2017-05-02 | 2018-11-08 | Merck Sharp & Dohme Corp. | Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies |
EP4351515A1 (en) * | 2021-06-11 | 2024-04-17 | Universidade Da Beira Interior | Self-emulsifying composition, production methods and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9405304D0 (en) * | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
JP2740153B2 (ja) * | 1995-03-07 | 1998-04-15 | エフ・ホフマン−ラ ロシユ アーゲー | 混合ミセル |
US6355631B1 (en) * | 2000-03-03 | 2002-03-12 | Aventis Pharma S.A. | Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation |
FR2814678B1 (fr) * | 2000-10-04 | 2002-12-20 | Aventis Pharma Sa | Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite |
FR2829027A1 (fr) * | 2001-08-29 | 2003-03-07 | Aventis Pharma Sa | Association avec un antagoniste du recepteur cb1, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de parkinson |
FR2833842B1 (fr) * | 2001-12-21 | 2004-02-13 | Aventis Pharma Sa | Compositions pharmaceutiques a base de derives d'azetidine |
-
2003
- 2003-07-18 EP EP03291797A patent/EP1498123A1/en not_active Withdrawn
-
2004
- 2004-07-01 PE PE2004000633A patent/PE20050699A1/es not_active Application Discontinuation
- 2004-07-08 SG SG200804302-8A patent/SG144140A1/en unknown
- 2004-07-08 RU RU2006105000/04A patent/RU2348615C2/ru not_active IP Right Cessation
- 2004-07-08 KR KR1020067001146A patent/KR20060040690A/ko not_active Application Discontinuation
- 2004-07-08 JP JP2006519900A patent/JP2009513559A/ja active Pending
- 2004-07-08 EP EP04741332A patent/EP1648441A1/en not_active Withdrawn
- 2004-07-08 MX MXPA06000478A patent/MXPA06000478A/es not_active Application Discontinuation
- 2004-07-08 NZ NZ544707A patent/NZ544707A/en unknown
- 2004-07-08 OA OA1200600017A patent/OA13190A/en unknown
- 2004-07-08 BR BRPI0412239-9A patent/BRPI0412239A/pt not_active IP Right Cessation
- 2004-07-08 WO PCT/EP2004/008552 patent/WO2005013972A1/en active Application Filing
- 2004-07-08 CA CA002532668A patent/CA2532668A1/en not_active Abandoned
- 2004-07-08 AU AU2004262497A patent/AU2004262497A1/en not_active Abandoned
- 2004-07-08 CN CNA2004800206437A patent/CN1822830A/zh active Pending
- 2004-07-08 RS YUP-2005/0971A patent/RS20050971A/sr unknown
- 2004-07-13 US US10/889,729 patent/US20050037062A1/en not_active Abandoned
- 2004-07-14 PA PA20048606601A patent/PA8606601A1/es unknown
- 2004-07-15 AR ARP040102494A patent/AR045912A1/es not_active Application Discontinuation
- 2004-07-16 MY MYPI20042870A patent/MY142076A/en unknown
- 2004-07-16 TW TW093121230A patent/TW200522946A/zh unknown
- 2004-07-16 UY UY28422A patent/UY28422A1/es unknown
- 2004-07-16 GT GT200400134A patent/GT200400134A/es unknown
- 2004-08-07 UA UAA200601706A patent/UA82539C2/uk unknown
-
2006
- 2006-01-06 CR CR8178A patent/CR8178A/es not_active Application Discontinuation
- 2006-01-12 IL IL173113A patent/IL173113A0/en unknown
- 2006-01-16 MA MA28725A patent/MA27921A1/fr unknown
- 2006-01-17 EC EC2006006291A patent/ECSP066291A/es unknown
- 2006-01-17 TN TNP2006000012A patent/TNSN06012A1/en unknown
- 2006-01-17 ZA ZA200600489A patent/ZA200600489B/xx unknown
- 2006-01-17 HR HR20060021A patent/HRP20060021A2/hr not_active Application Discontinuation
- 2006-01-31 NO NO20060510A patent/NO20060510L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1498123A1 (en) | 2005-01-19 |
SG144140A1 (en) | 2008-07-29 |
PA8606601A1 (es) | 2005-03-03 |
MA27921A1 (fr) | 2006-06-01 |
TNSN06012A1 (en) | 2007-10-03 |
CN1822830A (zh) | 2006-08-23 |
UA82539C2 (en) | 2008-04-25 |
RU2348615C2 (ru) | 2009-03-10 |
RU2006105000A (ru) | 2006-07-10 |
ZA200600489B (en) | 2007-04-25 |
WO2005013972A1 (en) | 2005-02-17 |
CR8178A (es) | 2007-12-04 |
EP1648441A1 (en) | 2006-04-26 |
ECSP066291A (es) | 2006-07-28 |
UY28422A1 (es) | 2005-02-28 |
JP2009513559A (ja) | 2009-04-02 |
CA2532668A1 (en) | 2005-02-17 |
KR20060040690A (ko) | 2006-05-10 |
NZ544707A (en) | 2009-01-31 |
AU2004262497A1 (en) | 2005-02-17 |
MY142076A (en) | 2010-08-30 |
OA13190A (en) | 2006-12-13 |
BRPI0412239A (pt) | 2006-09-12 |
AU2004262497A2 (en) | 2005-02-17 |
HRP20060021A2 (en) | 2006-02-28 |
TW200522946A (en) | 2005-07-16 |
IL173113A0 (en) | 2006-06-11 |
PE20050699A1 (es) | 2005-09-15 |
AR045912A1 (es) | 2005-11-16 |
NO20060510L (no) | 2006-01-31 |
US20050037062A1 (en) | 2005-02-17 |
MXPA06000478A (es) | 2006-04-05 |
RS20050971A (en) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL372809A1 (en) | Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof | |
SE0001899D0 (sv) | New compounds | |
BRPI0409133A (pt) | formulações farmacêuticas contendo metilnaltrexona | |
PA8591701A1 (es) | Derivados de pirrolopirimidina | |
BRPI0412851A (pt) | benzamidazóis de n-metila-substituìdos | |
PE20081506A1 (es) | Formulaciones de ansamicina | |
ECSP066365A (es) | Anilino purinas sustituidas en la posición 6 útiles como inhibidores de rtk | |
TW200716628A (en) | Novel compounds | |
UY30316A1 (es) | Derivados sustituidos de benzamidas, nicotinamidas, propanamidas, acetamidas y carboxamidas n-(2-(piperidin-1-ilmetil)ciclohexil)sustituidas, procesos de preparacion, composiciones conteniéndolos y aplicaciones | |
ATE497770T1 (de) | Pharmazeutische formulierungen von decitabin | |
UY31334A1 (es) | 3a,4,5,6,7,7a-hexahidro-3h-benzoimidazol y derivaods de 3a, 4,5,6,,7,7a-hexahidro-3-indol, enantiómeros, diastereoisómeros, sales farmacéuticamente aceptadas, mezclas, composiciones, preparaciones y aplicaciones de las mismas | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
PA8606201A1 (es) | DERIVADOS DE PIRROLO[3,4-c) PIRAZOL ACTIVOS COMO INHIBIDORES DE QUINASA, PROCESO PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN | |
SE0201544D0 (sv) | Novel compounds and thier use | |
SE0401342D0 (sv) | Therapeutic compounds | |
ECSP088829A (es) | Derivados de bencimidazol 5-sulfonamida como ligandos del receptor cannabinoide 1 (cb1) | |
TW200716152A (en) | Substituted 1,2-ethylendiamines, medicaments comprising said compound, their use and their method of manufacture | |
ECSP066860A (es) | Formulaciones de matriz oral que comprenden licarbazepina | |
GT200400134A (es) | Sistemas emulsionantes que contienen derivados de azetidina | |
UY28536A1 (es) | Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos. | |
SE0301701D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
UY30363A1 (es) | Derivados sustituidos de la n-(3-oxo-2,3-dihidro-1h-isoindol-4-il)-1-naftamida, procesos de preparacion, composiciones farmacéuticas y aplicaciones | |
NI200300045A (es) | Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa. | |
SE0301699D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
BRPI0416188A (pt) | formulações de medicamentos que contêm aromatizante, com propriedades farmacêuticas aperfeiçoadas |